Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasis

British Journal of Clinical Pharmacology

Volumn 54, Issue 2, 2002, Pages 147-156

  Chládek, Jaroslav ^a   Grim, Jiø ^a   Martínková, Jiøina ^a   Šimková, Marie ^b   Vanèková, Jaroslava ^b   Koudelková, Vra ^b   Noièková, Marie ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

AUC; Methotrexate; PASI score; Psoriasis

Indexed keywords

METHOTREXATE;

ADULT; AGE; AGED; ANALYSIS OF VARIANCE; ARTICLE; BIOCHEMISTRY; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SCREENING; FEMALE; GENDER; GENETIC VARIABILITY; HEMATOLOGICAL PARAMETERS; HUMAN; KIDNEY CLEARANCE; MALE; MONITORING; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SKIN DISEASE; STEADY STATE; TIME;

ADULT; AGED; DERMATOLOGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES; PSORIASIS;

EID: 0036039938     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2002.01621.x     Document Type: Article

References (29)

1. Non-linear renal elimination kinetics of methotrexate due to saturation of renal tubular reabsorption
2. Methotrexate revisited. Effects of long-term treatment in psoriasis
3. Clinical pharmacokinetics of low-dose methotrexate in rheumatoid arthritis
4. Methotrexate - The therapy rapidly acting drug
5. Methotrexate treatment of rheumatoid arthritis: Is a fortnightly maintenance schedule enough?
6. Methotrexate in rheumatoid arthritis. An update
7. Pharmacokinetics of low doses of methotrexate in patients with psoriasis over the early period of disease
8. Validation of sickness impact profile and psoriasis disability index in psoriasis
9. Determination of methotrexate and its metabolites 7-hydroxymethotrexate and 2,4 diamino-N10-methylpteroic acid in biological fluids by liquid chromatography with fluorimetric detection
10. Formation and disposition of 7-hydroxymethotrexate in rabbits
11. Trace analysis of methotrexate and 7-hydrozymethotrexate in human plasma and urine by a novel high-performance liquid chromatographic method
12. Correlation between methotrexate pharmacokinetic parameters, and clinical and biological status in rheumatoid arthritis patients
13. Methotrexate kinetics in rheumatoid arthritis: Is there an interaction with nonsteroidal anti-inflammatory drugs?
14. Intraindividual variability of the bioavailability of low dose methotrexate after oral administration in rheumatoid arthritis
15. Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: Association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy
16. Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis
17. Pharmacokinetics of small doses of methotrexate in patients with psoriasis
18. Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients
19. Methotrexate pharmacokinetics in patients with rheumatoid arthritis
20. Drug-drug interactions with antirheumatic agents. Review of selected clinically important interactions
21. Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flubiprofen in patients with rheumatoid arthritis
22. The population pharmacokinetics of long-term methotrexate in rheumatoid arthritis
23. Clinical pharmacokinetics of methotrexate
24. Effect of etodolac on methotrexate pharmacokinetics in patients with rheumatoid arthritis
25. Effect of urine pH and flow on renal clearance of methotrexate
26. The pharmacokinetics of methotrexate and 7-hydroxy metabolite in patients with rheumatoid arthritis
27. Total and free methotrexate pharmacokinetics, with and without piroxicam, in rheumatoid arthritis patients
28. Methotrexate in rheumatoid arthritis - A limited sampling strategy for estimation of the area under the plasma concentration versus time curve